Jpmorgan Chase & CO ALNYLAM PHARMACEUTICALS INC Transaction History

Jpmorgan Chase & CO

  • $1.27 Trillion
  • Q1 2025
Number of Shares
5,550,000
Previous 4,272,000 29.92%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 12, 2025
BUY
N/A
1,278,000 Added 29.92%
5,550,000 $0
Q4 2024

Feb 12, 2025
BUY
N/A
1,022,000 Added 31.45%
4,272,000 $0
Q3 2024

Dec 26, 2024
SELL
N/A
-3,627,000 Reduced 52.74%
3,250,000 $0
Q3 2024

Nov 08, 2024
SELL
N/A
-3,627,000 Reduced 52.74%
3,250,000 $0
Q2 2024

Dec 26, 2024
BUY
N/A
3,627,000 Added 111.6%
6,877,000 $0
Q2 2024

Aug 12, 2024
BUY
N/A
5,702,000 Added 485.28%
6,877,000 $0
Q1 2024

Dec 26, 2024
SELL
N/A
-2,075,000 Reduced 63.85%
1,175,000 $0
Q1 2024

May 10, 2024
BUY
N/A
1,060,000 Added 921.74%
1,175,000 $0
Q4 2023

Dec 26, 2024
SELL
N/A
-3,135,000 Reduced 96.46%
115,000 $0
Q4 2023

Feb 12, 2024
SELL
N/A
-415,000 Reduced 78.3%
115,000 $0
Q3 2023

Nov 14, 2023
BUY
N/A
530,000 New
530,000 $0
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email